Document is current
Any future updates will be listed below
-
Authors
Lichtiger, Anna B.
Deng, Yuting
Zhang, Chenshu
Groeger, Justina
Perez, Hector R.
Nangia, Gayatri
Prinz, Melanie
Richard, Emma
Glenn, Matthew
De La Cruz, Ana Alicia
Pazmino, Ariana
Cunningham, Chinazo O.
Amico, K Rivet
Fox, Aaron
Starrels, Joanna L. https://orcid.org/0000-0002-1865-1966
-
Funding
Funding for this research was provided by:
National Institute of Health (R01DA044171, K24DA046309, K23DA044327, K23DA055752)
- License Information
-
More Information
Article History
Received: 2 January 2024
Accepted: 26 March 2024
First Online: 29 May 2024
Declarations
:
: The Albert Einstein College of Medicine Office of Human Research Affairs, the institutional review board, approved the PIMENTO study. All participants in the PIMENTO study completed written informed consent. In the recruitment process, no participants were asked about prior incarceration history and no prisoners were enrolled in the study. All ethical standards to protect human subjects were followed in accordance with the Albert Einstein College of Medicine Office of Human Research Affairs.
: Not applicable.
: JLS has received research support from the FDA-mandated Opioid Post-Marketing Requirement Consortium for work on an observational study of the risks of opioids prescribed for chronic pain.
